Seattle Biotech Neovia Begins Clinical Trial for Immunotherapy Enhancing Cancer Drug – PR Newswire (press release)
|
Seattle Biotech Neovia Begins Clinical Trial for Immunotherapy Enhancing Cancer Drug
PR Newswire (press release) SEATTLE, Jan. 25, 2017 /PRNewswire-USNewswire/ — Seattle biotech Neovia Oncology has enrolled its first patient into a Phase 1 clinical trial for its lead cancer drug NEV-801, a novel, multi-inhibitor drug able to enhance immunotherapy response in … |
